Share-based Compensation (Tables)

3 Months Ended

Sep. 30, 2022

Equity [Abstract]

Schedule of Stock Options Roll Forward

The following table summarizes activity relating to holders of the Company’s NQSOs for the three months ended September 30, 2022:

	Number of:
	Nonperformance based vesting NQSO's	Weighted average exercise price		Weighted Average remaining contractual term (in years)	Aggregate Intrinsic value
Balance:
June 30, 2022	3,657,833	$	1.04	0.6	$	1,824,232
September 30, 2022	5,848,387	$	1.17	1.33	$	—
Exercisable at:
June 30, 2022	2,997,972	$	1.04	0.14	$	1,806,539
September 30, 2022	3,261,681	$	1.07	0.29	$	—

Schedule of RSU Activity

The following table summarizes activity relating to holders of the Company’s RSUs for the three months ended September 30, 2022:

	Number of:
	Nonperformance based vesting RSU's	Weighted-Average Fair Value Per Share At Date of Grant
Outstanding award balance as of June 30, 2022	1,100,000	$	1.02
Granted	100,000	0.74
Exercised	—	—
Outstanding award balance as of September 30, 2022	1,200,000	$	1.00
Vested	450,000	1.07
Unvested	750,000	1.17

Schedule of Earnings Per Share

The following is a reconciliation of the number of shares used in the calculation of basic earnings per share and diluted earnings per share for the three months ended September 30, 2022, and September 30, 2021:

	For the three months ended September 30,
	2022		2021
Net income (loss)	$	1,273,783	$	(2,139,000)
Weighted-average number of common shares outstanding at 9/30/2022	65,289,116		41,422,781
Warrants to purchase common stock (Blue Torch)	3,475,611		—
Convertible preferred stock	134,252,459		—
Diluted weighted-average number of common shares outstanding at 9/30/2022	203,017,186		41,422,781
Net earnings (loss) per share:
Basic	$	0.02	$	(0.05)
Diluted	$	0.01	$	(0.05)